Ondansetron HCL 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FM8Q8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,540
Award facts
- Contract value 100% obligated
- $20,540.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20,540.40 delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Ondansetron HCl 4 mg tablets (30-count units). This firm fixed-price delivery order, with an ultimate completion date of January 5, 2026, represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and operates as a child contract under the organization's larger indefinite delivery vehicle with DLA.
This delivery order falls under AmerisourceBergen's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX) that extends through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Ondansetron is an anti-nausea medication commonly used in military and veteran healthcare settings, and this procurement reflects the ongoing operational medical supply needs managed through DLA's established prime vendor relationships.
Quick answers
Who was awarded contract SPE2DR26FM8Q8?
SPE2DR26FM8Q8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26FM8Q8 worth?
The government has obligated $20,540 on SPE2DR26FM8Q8.
Is contract SPE2DR26FM8Q8 an order under another contract?
Yes. SPE2DR26FM8Q8 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM8Q8 competed?
The extent of competition for SPE2DR26FM8Q8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award